eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.52Daily change unavailable

Delayed quote: Oct 6, 2026, 9:32 AM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T13:42:20.647Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:42:20.647Z.

Quote observation: 2026-10-06T13:32:38.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 51,233,102
TTM free cash flow · period ending 2026-06-30: -7,141,124

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EXOZ Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

EXOZ Competitors' Price/FCF Ratio

EXOZ

eXoZymes, Inc.

Current

Market Cap

$51.23M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INMB

INmune Bio, Inc.

vs EXOZ

Market Cap

$51.71M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$51.78M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs EXOZ

Market Cap

$50.72M

Price/FCF Ratio

2.58

TTM Avg

2.45

3Y Avg

5.29

5Y Avg

4.64

APLM

Apollomics, Inc.

vs EXOZ

Market Cap

$50.51M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs EXOZ

Market Cap

$50.90M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs EXOZ

Market Cap

$49.58M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs EXOZ

Market Cap

$52.80M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs EXOZ

Market Cap

$53.01M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTB

Connect Biopharma Holdings Limited

vs EXOZ

Market Cap

$54.79M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$51.23M	N/A	N/A	N/A	N/A
INmune Bio, Inc. (INMB)vs ›	$51.71M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.78M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$50.72M	2.58	2.45	5.29	4.64
Apollomics, Inc. (APLM)vs ›	$50.51M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$50.90M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$49.58M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.80M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$53.01M	N/A	N/A	N/A	N/A
Connect Biopharma Holdings Limited (CNTB)vs ›	$54.79M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

EXOZ Price/FCF Ratio Metrics

EXOZ Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics